XPENG INC - ADR (XPEV)
US98422D1054 - ADR
Taking everything into account, XPEV scores 3 out of 10 in our fundamental rating. XPEV was compared to 42 industry peers in the Automobiles industry. XPEV may be in some trouble as it scores bad on both profitability and health. XPEV is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year XPEV has reported negative net income.
In the past year XPEV has reported a negative cash flow from operations.
XPEV had negative earnings in each of the past 5 years.
XPEV had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
XPEV has a Return On Assets of -10.52%. This is comparable to the rest of the industry: XPEV outperforms 57.14% of its industry peers.
Looking at the Return On Equity, with a value of -23.19%, XPEV is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.52% | ||
| ROE | -23.19% | ||
| ROIC | N/A |
ROA(3y)-10.84%
ROA(5y)-18.73%
ROE(3y)-21.62%
ROE(5y)-48.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XPEV's Gross Margin of 12.27% is in line compared to the rest of the industry. XPEV outperforms 52.38% of its industry peers.
XPEV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XPEV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.51%
GM growth 5YN/A
2. Health
2.1 Basic Checks
XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPEV has been increased compared to 1 year ago.
Compared to 5 years ago, XPEV has more shares outstanding
Compared to 1 year ago, XPEV has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that XPEV is in the distress zone and has some risk of bankruptcy.
XPEV has a better Altman-Z score (0.95) than 61.90% of its industry peers.
XPEV has a Debt/Equity ratio of 0.59. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
XPEV has a Debt to Equity ratio (0.59) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.95 |
ROIC/WACCN/A
WACC9.86%
2.3 Liquidity
A Current Ratio of 1.50 indicates that XPEV should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.50, XPEV is in line with its industry, outperforming 54.76% of the companies in the same industry.
XPEV has a Quick Ratio of 1.31. This is a normal value and indicates that XPEV is financially healthy and should not expect problems in meeting its short term obligations.
XPEV has a Quick ratio of 1.31. This is in the better half of the industry: XPEV outperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 52.91% over the past year.
XPEV shows a strong growth in Revenue. In the last year, the Revenue has grown by 66.09%.
Measured over the past years, XPEV shows a very strong growth in Revenue. The Revenue has been growing by 398.15% on average per year.
EPS 1Y (TTM)52.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.68%
Revenue 1Y (TTM)66.09%
Revenue growth 3Y73.79%
Revenue growth 5Y398.15%
Sales Q2Q%18.43%
3.2 Future
XPEV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.52% yearly.
The Revenue is expected to grow by 25.58% on average over the next years. This is a very strong growth
EPS Next Y53.73%
EPS Next 2Y31.81%
EPS Next 3Y26.03%
EPS Next 5Y18.52%
Revenue Next Year31.09%
Revenue Next 2Y45.74%
Revenue Next 3Y37.72%
Revenue Next 5Y25.58%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for XPEV. In the last year negative earnings were reported.
Also next year XPEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
XPEV's earnings are expected to grow with 26.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.81%
EPS Next 3Y26.03%
5. Dividend
5.1 Amount
No dividends for XPEV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
XPENG INC - ADR
NYSE:XPEV (12/13/2024, 8:04:00 PM)
After market: 12.32 +0.02 (+0.16%)12.3
-0.51 (-3.98%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.65B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.52% | ||
| ROE | -23.19% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.27% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)52.91%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y53.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)66.09%
Revenue growth 3Y73.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y